Comments on the AGA Clinical Practice Update on Diagnosis and Management of Cannabinoid Hyperemesis Syndrome

Gastroenterology. 2024 Oct;167(5):1055-1056. doi: 10.1053/j.gastro.2024.06.026. Epub 2024 Jun 28.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antiemetics / adverse effects
  • Antiemetics / therapeutic use
  • Cannabinoid Hyperemesis Syndrome
  • Cannabinoids* / adverse effects
  • Gastroenterology / standards
  • Humans
  • Practice Guidelines as Topic
  • Syndrome
  • Vomiting* / chemically induced
  • Vomiting* / therapy

Substances

  • Cannabinoids
  • Antiemetics